Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Anteris Technologies Global Corp. Capital/Financing Update 2018

Dec 3, 2018

33869_rns_2018-12-03_b6ebd37e-60ef-4648-816c-0d7472a5540c.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

4.12.2018

==> picture [451 x 24] intentionally omitted <==

ASX ANNOUNCEMENT

ASX Market Announcements Australian Securities Exchange Limited 20 Bridge Street SYDNEY NSW 2000

Admedus Limited (ASX:AHZ)

DESPATCH OF LETTERS TO ELIGIBLE AND INELIGIBLE SHAREHOLDERS

Admedus Limited ( Admedus ) advises that letters were despatched to shareholders on 28 November 2018 via post and on 29 November 2018 via email advising them whether they have been determined to be eligible or ineligible to participate in the renounceable pro-rata entitlement offer ( Entitlement Offer ) announced to ASX on Wednesday, 28 November 2018.

A template copy of the letters sent to shareholders are attached.

The Entitlement Offer opens today, Tuesday, 4 December 2018, and is scheduled to close at 5:00 pm (AEDT) on Thursday, 13 December 2018.

If you are an eligible shareholder and do not receive a copy of the prospectus or have any questions in relation to your entitlement under the Entitlement Offer, please contact the Share Registry, Computershare, via the details listed below.

Shareholders should also note that trading in Admedus’ rights in relation to the Entitlement Offer (ASX: AHZRA) is currently underway and will end on Thursday, 6 December 2018.

ENDS

Admedus Limited

T: 1300 550 310 F: 1300 880 398 International: T: +61 (0)7 3152 3200 F: +61 (0)7 3152 3299 E: [email protected] W: admedus.com

==> picture [72 x 72] intentionally omitted <==

Registered Office: Level 9, 301 Coronation Drive, Milton, Queensland 4064

Customer Service:

Brisbane • Minneapolis • Geneva • Singapore AUI-930502815v1

ABN 35 088 221 078

==> picture [451 x 24] intentionally omitted <==

About Admedus Limited

Admedus (ASX:AHZ) is a medical technologies company delivering clinically superior solutions that help healthcare professionals create life-changing outcomes for patients. Our focus is on investing in and developing next generation technologies with world class partners, acquiring strategic assets to grow product and service offerings and expanding revenues from our existing medical sales and distribution business. The company has assets from research & development through clinical development as well as sales, marketing and distribution.

Website: www.admedus.com

Facebook: www.facebook.com/Admedus

Twitter: @Admedus

For more information, please contact:

Share Registry

Computershare Investor Services Pty Ltd Telephone: 1300 557 010 (within Aust) +61 3 9415 4000 (outside Aust) Facsimile: +61 3 9473 2500

Investor Relations

Kyahn Williamson WE Buchan [email protected] 03 9866 4722

AUI-930502815v1

==> picture [15 x 32] intentionally omitted <==

==> picture [14 x 32] intentionally omitted <==

==> picture [15 x 32] intentionally omitted <==

==> picture [14 x 32] intentionally omitted <==

==> picture [15 x 32] intentionally omitted <==

==> picture [14 x 32] intentionally omitted <==

==> picture [14 x 32] intentionally omitted <==

==> picture [7 x 32] intentionally omitted <==

NOT FOR DISTRIBUTION OR RELEASE IN THE UNITED STATES

AHZ

MR SAM SAMPLE FLAT 123 123 SAMPLE STREET THE SAMPLE HILL SAMPLE ESTATE SAMPLEVILLE VIC 3030

2 9 N o v e m b er 20 1 8

D e ar S h ar e holder,

RENOUNCEABLE ENTITLEMENT OFFER – NOTICE TO ELIGIBLE SHAREHOLDERS

A d m e d u s L i m ite d A C N 0 8 8 2 2 1 078 ( Admedus o r Company ) anno u nced o n W e d ne s d a y, 28 N o v e m b er 20 1 8 t ha t it i s u nd e rt a ki n g a r e no u n c eable pr o -r a ta en t itlement o ff e r ( Entitlement Offer ) to raise up to $2 0 .2 mi l lio n , b ef o re c o s ts. T h e p ro c e e ds of t he E n titl e m e nt Of f er w ill pr o vi d e f un d s f or A d m e d u s to:

  • re p ay th e e x is t in g lo a n from S tar B rig h t H ol d in g L imite d ( Star Bright ) to th e a m o u nt of $5 millio n pl u s a n y a c cr u ed int e r e st;

  • m e et c er t ai n restr u ct u ri n g c os t s; fu n d re s earc h a nd d ev e lo p m e nt p roj e ct s i ncluding t h e Tr a n s ca t he t er Aortic Valve Replace m e n t ( T A V R ) proje c t; a n d

  • fu n d g en e ral w o rk i ng ca p it a l a n d o p e ra t io n al c osts.

T h e E n t itlement O ff e r is p art i all y u n d e rw r itt e n f or $9.1 m illion an d commi t m e nt s h a ve been re c ei v ed fr o m ex i sti n g s h a re h ol d er s f o r a fu r th e r $ 4 m ill i on . U p t o a fu r th e r $6.3 m i llion i n u n d e rw r iti n g w ill be p r ovi d e d if A d m e d u s d o es not r a ise a m inim u m of n et $1 2 m illi o n i n c as h u n d e r t h e E nt i tle m e n t O ff e r.

Details of the Entitlement Offer

T h e En t itl e m e nt Of f er is be i ng m a d e und e r a t r an s a c tio n -s p e c ifi c p r os p e c tu s in a c cord a nc e w ith s e cti o n 7 1 3 o f th e Cor p or a tio n s A c t 2 0 01 (C t h) ( Corporations Act ). S h ar e h o ld e rs w h o are e ligibl e to parti c ipate in t h e E ntitle m ent O ff e r a re t ho s e pe r so n s w h o :

  • ar e regis t er e d a s a h o ld e r o f f u lly p a id o rd i na r y s ha r es in th e C o m p a n y a s a t 7:00 p m ( A E D T) on M o nd a y, 3 D e c e m be r 2 0 1 8 ( Record Date ) ;

  • ha v e a r egistere d a d dr e s s o n A d m edus’ s h ar e r e gi s ter th a t i s in A u s tra l ia, N e w Ze a la n d, Hong Kong, Si n g a pore o r t he Philip p in e s t o t he ex t en t A d m e d u s c an m a ke th e o f fe r in th o se jurisdicti o ns in a c c or d ance w it h a p pl i ca b le se c uritie s la w s ;

Samples/000001/000001

==> picture [15 x 32] intentionally omitted <==

==> picture [14 x 32] intentionally omitted <==

==> picture [15 x 32] intentionally omitted <==

==> picture [14 x 32] intentionally omitted <==

==> picture [15 x 32] intentionally omitted <==

==> picture [14 x 32] intentionally omitted <==

==> picture [14 x 32] intentionally omitted <==

==> picture [7 x 32] intentionally omitted <==

  • ar e n o t i n t h e Un i te d S t at e s a nd a r e n ot (in c lu d in g a s no m in e e o r c us t odian ) a c ting f o r t he ac c ount o r b e n efi t of a p er s o n in th e U nit e d St a te s w i th respe c t t o t h ei r shar e s i n A d m ed u s, unles s A d m e d u s h as ot h er w is e d e termine d t h at p e r so n may pa r ticipa t e; a n d

  • ar e el i gi b le u n d er all ap p lic a bl e s e c u riti e s la w s t o r e ceive an of f er u n d er th e E n titlemen t O f fer wit h o u t any re q uir e m e nt fo r a p ro s p e ct u s o r offe r d o cu m e n t t o be l o dged or regist e re d ,

( Eligible Shareholder ).

Eligi b le Sh a r e holde r s m a y s u bscri b e f or 5 n e w fully paid o rdi n a r y s ha r es ( New Shares ) fo r e v er y 7 o r dinar y s h ar e s h el d o n t h e R e c or d D a te at an issue pri c e o f $ 0. 0 8 p er N e w S h a re . E a ch N e w S h a re in c lu d e s o n e f re e at t ac h in g opti o n ( New Option ) w it h a n e x er c is e p r ice of $0.08 p e r N e w O p ti o n a nd a n e x pi r y dat e of thr e e y e a rs fro m t h e d at e of is s u e .

N e w Shar e s u nd e r the En t itl e m e nt Offer w ill be fully p ai d a n d r an k e q u a lly in a ll r es p e c ts w it h e x ist i ng o r dinar y s h ar e s o n issue. N e w O p tio n s wil l b e li s te d and upon ex e rcise wi l l con v er t in t o f ull y p a id o r dinar y s h ar e s r an k in g e q u a lly in all re s pe c ts wi t h e xi s tin g o r di n ar y s h ar e s on issue when th e New O p ti o n i s e x er c is e d.

Eligibility to participate

Y o u h a v e b een sent this l e tter b e c a us e t h e C o m p a ny belie v es yo u a r e a n E li g ibl e S h a r eh o ld e r. If y ou a r e n ot an Eligible S h a re h ol d er , y o u c a n no t p a rti c ip a te in th e E n title m en t O f fe r . T h e C o mpa n y w ill n o tif y th o s e s h ar e h o ld e rs w h o a r e n ot Eli g ibl e S ha r eholders.

Entitlements

E n titlemen t s i n r e s p ec t o f N e w S h ar e s a n d New O p ti o ns will b e r o u n ded u p t o t he near e st w h o le n u m b er a n d hol d in g s on di f fe r en t r e gi s te r s o r s u b -regis t er s w ill no t b e a ggre g at e d t o cal c ul a te e n titl e m e nts.

E n titlemen t s a re re n ou n c e ab l e a nd th e re f or e if yo u d o not w ish t o t a ke yo u r e nt i tle m e n t y ou m a y s ell al l or part o f y o ur entitl e m e nt on A S X b et w e e n F ri d ay , 3 0 N o v e m b er 20 1 8 a n d T h ur s d a y, 6 D ec e m b er 2 0 18 (i n cl u si v e) or tra n sf e r a ll o r pa r t of y o u r e n titl e m e nt di r ec t ly to a n o th e r p er s o n . T h e re is no g u ar a nt e e t ha t t h er e w i ll b e a li q ui d mar k et in t r aded en t itl e m e nt s . A la c k o f liquidit y may im p a c t y o ur a b ilit y t o s e ll you r e n titl e m e nt s o n t h e A S X a n d t he price y o u may be able t o a c hi e ve.

In th e e v e n t t h at Eli g ible S hare h ol d er s d o n o t t a k e u p all o f th e ir e nt i tle m e n ts in f ull, a sh o rtf a ll f acility w i ll b e a va i la b le t o p ro v id e a n o p p o rtunit y for t h os e E ligible S h ar e holders t ha t h a ve ta k en u p th e ir f ull e n titl e m e nts t o a pp l y f or ad d iti o n a l N e w S h ar e s an d a tta c hi n g Ne w O p t io n s ( Additional Shares ). T h e all o ca t io n o f a n y A d d iti o n a l S ha r es u n de r t h e S h o rtf a ll F a c ilit y w ill b e at th e disc r eti o n o f t he di r ec t or s o f A d m e dus.

Prospectus

T h e C o m p an y w ill send a co p y of th e P ro s pectus, along wi t h a p er s o n ali s e d Enti t le m e n t a nd A c cept a nc e F or m , to all Eligi b le Sh a reholde r s o n Tues d ay, 4 D e c e m b er 2 0 18. A c o p y o f t he P r os p e c tu s h a s b ee n r e le a sed t o t h e A S X a n d lod g e d wi t h A SIC o n W e d n e sd a y, 28 N o ve m b e r 2 018.

F u rt h er de t ail s o f the E ntitle m e n t O ff e r i s i n cl u de d i n t h e P ro s p e ct u s. Eligi b le Sh a reholde r s s ho u ld read th e P ro s p e ct u s ca r efully and i n i ts en t irety be f or e deci d in g w h e th e r t o pa r ticipa t e in t he E n titlemen t O f fer.

==> picture [14 x 32] intentionally omitted <==

==> picture [15 x 32] intentionally omitted <==

==> picture [14 x 32] intentionally omitted <==

==> picture [15 x 32] intentionally omitted <==

==> picture [14 x 32] intentionally omitted <==

==> picture [15 x 32] intentionally omitted <==

==> picture [14 x 32] intentionally omitted <==

==> picture [6 x 32] intentionally omitted <==

Important dates

Ac
tiv
ity
D
st
ate
ate
(A
d)
ED
T u
nl
ess
ot
he
rwi
se
An
no
unc
em
en
t o
f En
titl
em
ent
Of
fer
W
2
ed
018
nes
da
y,2
8N
ov
em
be
r
Lo
dg
em
ent
of
Pro
sp
ect
us
wit
hA
SIC
an
dA
SX
W
2
ed
018
nes
da
y,2
8N
ov
em
be
r
En
titl
em
ent
sb
egi
n tr
ad
ing
on
AS
Xo
nd
efe
rre
ds
ett
lem
en
t ba
sis
F
rida
y,
30
No
vem
be
r2
018
Sh
are
sb
eg
int
o t
rad
eo
na
n “
ex-
ent
itle
me
nt”
bas
is
F
rida
y,
30
No
vem
be
r2
018
Re
En
co
titl
rd
em
Dat
ent
e fo
Of
rd
fer
ete
rm
inin
gE
lig
ible
S
har
eho
lde
rs
und
er
the
7
D
:00
ece
pm
mb
on
er
M
20
ond
18
ay
, 3
En
Ac
titl
ce
em
pta
ent
nce
Of
Fo
fer
rm
op
ss
ens
ent
an
to
dP
Eli
ro
gib
spe
leS
ctu
ha
sa
reh
nd
old
En
ers
title
me
nt
and
T
ues
da
y,4
D
ece
mb
er
201
8
Tr
adi
ng
ofE
nt
itle
me
nts
en
ds
T
hur
sda
y,
6D
ec
em
ber
20
18
En
titl
em
ent
Of
fer
clo
ses
5
D
:00
ece
pm
mb
on
er
T
20
hur
18
sda
y,
13
Iss
iss
ue
ue
Da
du
te
nde
a
rt
llot
he
me
Ent
nta
itle
nd
me
iss
nt
ue
Off
of
er
Ne
wS
ha
res
an
dN
ew
O
ptio
ns
M
on
day
, 1
7D
ec
em
ber
20
18
No
En
rm
titl
alt
em
rad
ent
ing
Of
of
fer
Ne
wS
ha
res
an
d
New
O
pti
ons
is
sue
du
nd
er
T
ues
da
y,1
8
D
ec
em
be
r 20
18
De
sp
atc
ho
f ho
ld
ing
sta
tem
en
ts
W
2
ed
018
nes
da
y,

19D
ec
em
be
r

Th i s ti m eta b le i s indicati v e o n ly and subject to cha n ge. Th e dir e ctor s of A dm e du s ma y va r y th e se d ate s su b jec t to t h e L i stin g Ru l es. A n extension of t he C losing D ate w ill d ela y the anti c ipa t ed d ate f or i s sue of t h e N e w S har e s a n d N e w O pti o ns. T he d ire c tors of A dm e dus also res e rve the r ight no t to p roc e ed w ith t he w hol e or p art o f the E n title m en t Off e r a n y ti m e b e for e the allo t me n t an d is s ue o f th e Ne w S h are s an d Ne w O p tion s . In that ev e nt, t he r e lev a nt a ppli c ation m o nie s (wi t hou t int e rest ) will be r etur n ed i n full to a ppli c ant s .

Th e co m m e nce m en t of q uot a tion of N ew S hares and N ew O pti o ns i s su b ject to t h e discre t ion o f A S X. C o olin g off rig h ts do n o t a p ply t o a n in v est m ent in N ew Sh a res and Ne w O p tion s . Y o u c ann o t w i thdr a w y our application o nce it has b een ac c ept e d.

Further information

F o r f urthe r infor m a t io n r e gardi n g th e Entitle m ent O ff e r, p le a s e c o nt a ct A d m e d u s’ sh a re re g is t ry, C o m p ut e rsha r e, o n 13 0 0 5 5 2 2 7 0 ( wit h in A u str a li a ) a n d +6 1 3 9415 40 0 0 ( ou t si d e A u s tra l ia) be t w e en 8.30 a m t o 5 . 00 p m ( A E S T ) M on d a y t o F r id a y d ur i ng th e o ffe r p e ri o d. Alter n ati v el y , c on t ac t y o ur st o c k br o ker, soli c ito r , a c c o un t an t o r ot h er pr o fe s si o nal a d vi s er.

O n b e h a lf o f t h e d ir e ct o rs, I t h ank y o u f or yo u r o ng o in g s u p p or t of Admedu s .

Y o ur s sinc e re l y,

J o hn S e ab e rg C h ai r m a n

Samples/000001/000002/i12

==> picture [14 x 32] intentionally omitted <==

==> picture [15 x 32] intentionally omitted <==

==> picture [14 x 32] intentionally omitted <==

==> picture [15 x 32] intentionally omitted <==

==> picture [14 x 32] intentionally omitted <==

==> picture [15 x 32] intentionally omitted <==

==> picture [14 x 32] intentionally omitted <==

==> picture [6 x 32] intentionally omitted <==

Important information

T h is lett e r is i s su e d b y A d m e d u s . This let t er is n ot a p ro s pe c tu s o r of f ering do c u m e n t u n d e r A us t ral i an la w o r u n d er an y o th e r l a w . It is for in f or m a t ion p u rp o s e s o nl y a n d do e s no t c o n s tit u te an of f er, in v it a tio n o r r e c o m m e n da t io n t o s u b s cri b e f or , r e tai n or pur c ha s e an y e n tit l e m ents o r s e c uri t ies in A d m e d u s i n any j urisdi c ti o n. T his l e tter d o e s n o t con s tit u te fin a n c ial pr o du c t a dv i ce an d doe s n o t a nd w i ll not f or m a n y p a r t o f a n y c on t ra c t f o r t h e a c q uisitio n o f e n titl e men t s or A d med u s s ecuri t ies.

T h is let t er m a y not b e rel e a s ed or distri b ut e d i n t h e U nited S t at e s. T hi s l e tter d o e s n o t c on s tit u te an o ff er to sell, o r t h e s olicit a tio n of a n offe r to b u y, a n y s e curiti e s in t h e Un i te d S t at e s o r t o , o r f o r t he a c co u nt or be n ef i t o f , any pe r so n i n th e U nit e d S t a te s . No a cti o n h a s b e en or wil l b e take n t o re g is t er, q u ali f y o r oth e rwise pe r mi t a p u b lic off e ri n g o f t h e N e w Sha r es in a n y ju r isdicti o n ou t side A us t ral i a a nd N e w Z e al a nd . I n p a rticul a r, th e N e w Sha r es a n d N e w O ption s h av e n ot been, a n d wil l n o t b e, regis t er e d u n d er th e U n it e d S ta t es S e cu r iti e s A ct of 1 9 3 3 ( US Securities Act ) o r the se c uritie s laws o f a n y s tat e or o t he r juris d ict i on of th e U n it e d S ta t es. A c co r di n gl y , t h e e nt i tle m e n ts , N e w Shar e s a nd N e w O p tio n s m a y n o t b e i ss u e d to , p u rc h ased or tra d e d b y , or t a ke n up o r e x e r cis e d by, a n y p er s on in th e Unit e d S tates or any p er s on actin g f o r t h e a c c ou n t o r b en e fit of a p er s on in th e Unit e d S ta t es e x ce p t p ur s u a nt t o a n e xemptio n fr o m , o r in a t r ansa c tio n n o t s ub j ec t to, t h e r e gi s tr a tion r e q u ire m e n ts o f th e U S S ec u rities A c t a n d a p p lic a bl e Unit e d S ta t es st a te s e c uri t ie s la w s.

==> picture [14 x 32] intentionally omitted <==

==> picture [14 x 32] intentionally omitted <==

==> picture [15 x 32] intentionally omitted <==

==> picture [14 x 32] intentionally omitted <==

==> picture [15 x 32] intentionally omitted <==

==> picture [14 x 32] intentionally omitted <==

==> picture [14 x 32] intentionally omitted <==

==> picture [8 x 32] intentionally omitted <==

NOT FOR DISTRIBUTION OR RELEASE IN THE UNITED STATES

AHZ

MR SAM SAMPLE FLAT 123 123 SAMPLE STREET THE SAMPLE HILL SAMPLE ESTATE SAMPLEVILLE VIC 3030

2 9 N o v e m b er 20 1 8

D e ar S h ar e holder,

RENOUNCEABLE ENTITLEMENT OFFER – NOTICE TO INELIGIBLE SHAREHOLDERS

A d m e d u s L i m ite d A C N 0 8 8 2 2 1 078 ( Admedus o r Company ) anno u nced o n W e d ne s d a y, 28 N o v e m b er 20 1 8 t ha t it i s u nd e rt a ki n g a r e no u n c eable pr o -r a ta en t itlement o ff e r ( Entitlement Offer ) to raise up to $2 0 .2 mi l lio n , b ef o re c o s ts. T h e p ro c e e ds of t he E n titl e m e nt Of f er w ill pr o vi d e f un d s f or A d m e d u s to:

  • re p ay th e e x is t in g lo a n from S tar B rig h t H ol d in g L imite d ( Star Bright ) to th e a m o u nt of $5 millio n pl u s a n y a c cr u ed int e r e st;

  • m e et c er t ai n restr u ct u ri n g c os t s; fu n d re s earc h a nd d ev e lo p m e nt p roj e ct s i ncluding t h e Tr a n s ca t he t er Aortic Valve Replace m e n t ( T A V R ) proje c t; a n d

  • fu n d g en e ral w o rk i ng ca p it a l a n d o p e ra t io n al c osts.

T h e E ntitle m e n t O ff e r i s p a rti a lly unde r writte n f o r $ 9 .1 millio n a n d c o m mitm e nts hav e b e e n re c ei v e d fr o m existi n g s hare h older s fo r a f ur t he r $ 4 milli o n. U p to a f u rther $ 6. 3 m illi o n in u nd e r w riti n g w ill be p r ovi d e d if A d m e d u s d o es not r a ise a m inim u m of n et $1 2 m illi o n i n c as h u n d e r t h e E nt i tle m e n t O ff e r.

Details of the Entitlement Offer

T h e E ntitle m e n t O ff e r i s b e in g mad e u n d e r a tr a ns a ction - sp e ci f ic p ro s p e ct u s i n a c cord a nc e w ith s e cti o n 7 1 3 o f th e Cor p or a tio n s A c t 2 0 01 (C t h) ( Corporations Act ).

U n d e r t h e E ntitle m e n t O ff e r, s h a re h ol d er s th a t a re en t itl e d t o p a rti c ip a te m a y s ub s cribe fo r 5 n e w fully p a id o rdin a ry s h a re s ( New Shares ) fo r e v er y 7 o rdinary s h a re s h e ld o n t he R e co r d D at e a t a n is s u e p r ice of $0.08 pe r N e w Sh a r e . E a c h N e w Shar e in c lu d es one f r ee att a c h in g o p tion ( New Option ) with a n e x er c is e p r ice of $0.08 pe r N e w O p tio n a n d a n e x p iry da t e o f t h re e y e ar s f r o m th e d a te of iss u e.

T h is is a le t te r to inf o r m y o u t h at, a c co r di n g to o ur r ec o rds, y ou d o n o t s a tisfy the eli g ibi l ity cri t eri a t o p a rti c ip a te in the En t itl e m e nt O ff e r.

Samples/000001/000001

==> picture [14 x 32] intentionally omitted <==

==> picture [14 x 32] intentionally omitted <==

==> picture [15 x 32] intentionally omitted <==

==> picture [14 x 32] intentionally omitted <==

==> picture [15 x 32] intentionally omitted <==

==> picture [14 x 32] intentionally omitted <==

==> picture [14 x 32] intentionally omitted <==

==> picture [8 x 32] intentionally omitted <==

Why am I not eligible to participate in the Entitlement Offer?

  • S h ar e h o ld e rs w h o are e ligibl e to parti c ipate in t h e E ntitle m ent O ff e r a re t ho s e pe r so n s w h o : ar e regis t er e d a s a h o ld e r o f f u lly p a id o rd i na r y s ha r es in th e C o m p a n y a s a t 7:00 p m ( A E D T) on M o nd a y, 3 D e c e m be r 2 0 1 8 ( Record Date ) ;

  • ha v e a r e gi s ter e d ad d re s s o n A d m e d u s ’ s h ar e r e gi s ter th a t i s in Austr a li a , New Zealand, Hong Ko n g, Si n g a po r e o r t h e P hilip p in e s t o t h e e xt e nt A d m e d u s c a n m a k e the off e r i n t h os e jurisdicti o ns in a c c or d ance w it h a p pl i ca b le se c uritie s la w s ;

ar e n o t i n th e U nit e d S t a te s a n d a re no t (i n cluding a s no m in e e o r c u st o di a n) ac t in g for t h e ac c ount o r b en e fit of a per s on in t he U n ite d S t at e s w it h resp e ct t o their s h ar e s i n A d m edus, unles s A d m e d u s h as ot h er w is e d e termine d t h at p e r so n may pa r ticipa t e; a n d • ar e el i gi b le u n d er a ll a p p lic a bl e s e curiti e s law s t o recei v e a n o ff e r u nd e r t he En t itl e m e nt O ff e r wit h o u t any re q uir e m e nt fo r a p ro s p e ct u s o r offe r d o cu m e n t t o be l o dged or regist e re d , ( Eligible Shareholder ). A d m e d u s h as de t er m ined, p u rs u an t to se c ti o n 9 A( 3 ) o f t h e C o r po r ati o n s A c t and Listin g R u le 7. 7 .1 ( a) o f th e A S X Li s tin g R ules, tha t it w o u ld be un r ea s o n ab l e t o m ak e offe r s t o s h ar e h o ld e rs in c ountries o u tsi d e o f A u s tralia, N e w Z e a la n d, H o n g K o n g, Si n ga p o r e a nd th e P h ili p pi n es in c o n ne c ti o n w ith th e E n titlemen t O f fer. This is d u e to th e legal and r e g u lat o ry re q ui r e m en t s i n c o u n tri e s o th e r t h a n A u st r ali a , N e w Z e al a nd, Sing a p o re, H o ng K o ng and t h e P hilip p in e s, a n d th e pot e nti a l cost s t o A d m e d u s o f c o m p ly i ng with t h e s e r e q u irements, c o m p ar e d w it h t h e r e la t iv e ly s m a ll n u m b e r o f s h ar e h o ld e rs in t h o s e c ou n tri e s, th e relati v el y s m a l l n u m b er of exi s ti n g A d m e d us or d in a ry s h a re s they h o ld a n d the r e la t iv e ly l o w va l ue of N e w S hares and N e w O p ti o ns to w hich th o se sh a re h ol d e r s w ou l d othe r wi s e b e e ntitle d to subs c ribe f o r.

U n fo r tu n at e ly, acco r ding t o o u r rec o rd s , y ou do no t s a tis f y t h e e ligibil i ty c rit e ri a for a n E l igi b le S h ar e h o ld e r stat e d a b o ve . Acc o rdingl y , i n c o m p li a nc e w ith se c tion 9A( 3 )( b ) o f the C or p or a ti o ns Ac t a n d A S X L i sti n g R ule 7.7. 1 (b ) , t h is l ett e r i s t o in f or m y ou th a t Admed u s h a s d e ter m i n ed th a t you ar e n o t an E ligibl e S h ar e h o ld e r a n d, th e re f or e , are ineligi b le t o e xerci s e y ou r e n titl e men t to be issue d N e w Sh a r e s a nd New O ption s u n d e r t h e E ntitle m ent O ff e r.

T h e E ntitle m e n t O ff e r i s r e no u n c ea b le an d Eligi b le S h ar e holders w ill be able t o tr a d e their e n titl e m e nts duri n g t he off e r p eriod. H o w e ver, a s you ar e n o t an E ligible S h ar e holder y o u w ill no t b e a b le t o t ra d e y ou r e n titl e m e nts.

What happens to my entitlement?

A d m e d u s h as appli e d t o A SI C f o r t h e a p p ointm e nt of a n o minee ( Nominee ) f o r t h e p ur p o s es of s e cti o n 6 1 5 o f th e Cor p or a tio n s A ct to arr a n g e f or t he sa l e o f t h e e nti t le m e n ts w h i ch would h a ve be e n o ff er e d t o s ha r eholders w h o a re no t Eligi b le S h a re h ol d er s ( Ineligible Shareholders ) h a d s u c h p e rs o ns b e en eli g ible t o p a rti c ip a te in t he Entitl e m e nt Of f er. Th e N o m in e e w ill arr a n g e f or p ro c e e ds of s a le ( if a ny), net o f s ub s cripti o n c osts a nd e x pe n s e s, t o b e s en t p r op o rti o n a lly to e a c h I n eligible S h ar e h o ld e r t h ro u g h A d m e d u s’ s h a re r egist r y.

T h e N o m inee wil l h a ve th e a b so l ut e a n d s ol e di s cr e ti o n t o det e rm i ne th e ti m in g and the pr i ce at w hich the E nti t le m e n ts m a y b e s o ld an d t h e m a n n e r o f a n y s al e . N eit h er A d m e du s n o r t he Nomi n ee wi l l b e s u bj e ct t o a ny lia b ili t y f o r t h e f ail u re to s el l th e E nti t le m e n ts a t a p a rti c ul a r pric e .

You are not required to do anything in response to this letter.

==> picture [14 x 32] intentionally omitted <==

==> picture [15 x 32] intentionally omitted <==

==> picture [14 x 32] intentionally omitted <==

==> picture [15 x 32] intentionally omitted <==

==> picture [14 x 32] intentionally omitted <==

==> picture [15 x 32] intentionally omitted <==

==> picture [14 x 32] intentionally omitted <==

==> picture [8 x 32] intentionally omitted <==

Further information

F o r f u rt h er inf o r m ati o n r egar d in g th e Enti t le m e n t Offe r , p l ea s e c o n ta c t A dmed u s o n A d m e d u s ’ s h ar e regis t ry, C o m p ut e rs h ar e , o n 1 300 5 52 27 0 ( w it h in A u s tr a lia ) a n d + 61 3 9 415 4 00 0 ( o ut s id e A u st r ali a ) b e tw e e n 8.30 a m to 5. 0 0 p m (A E S T ) M o n da y t o F r iday duri n g t he off e r p eriod . Al t er n ativel y , c on t ac t y o ur stock b ro k er, s o lici t or, acco u nt a nt or o th e r p ro f es s io n al ad v is e r.

O n b e h a lf o f t h e D ir e ct o rs, th a n k y o u f o r y our o n g o in g s u pp o rt o f A d m e d us .

Y o ur s sinc e re l y,

J o hn S e ab e rg C h ai r m a n

Samples/000001/000002/i12

==> picture [14 x 32] intentionally omitted <==

==> picture [15 x 32] intentionally omitted <==

==> picture [14 x 32] intentionally omitted <==

==> picture [15 x 32] intentionally omitted <==

==> picture [14 x 32] intentionally omitted <==

==> picture [15 x 32] intentionally omitted <==

==> picture [14 x 32] intentionally omitted <==

==> picture [8 x 32] intentionally omitted <==

Important information

T h is lett e r is i s su e d b y A d m e d u s . T hi s le t ter is n ot a p ro s p e ctus o r o f fering docu m e n t u nd e r A u st r ali a n law or un d er any other l a w. It i s for i n for m a t io n p u rp o s e s only and doe s n o t c on s tit u te an o ff er, in v itatio n o r re c o m m e n d ation to s u b sc r ib e fo r , r e tain or p u rc h a s e a ny en t itl e m e nt s o r secu r ities in Adm e du s i n a n y j u ri s dictio n . T his le t ter do e s n ot co n st i tut e fi n a n ci a l p r oduct advic e a n d d o e s n ot a n d w ill no t fo r m an y p a rt o f a ny co n tr a ct f or th e a c qu i siti o n of e ntitle m e n ts or A d m e d u s s e cu r iti e s.

T h is lett e r m a y n o t b e r e le a s e d o r d ist r ibute d in th e U n it e d S tates. T h is lett e r d oe s n o t c on s tit u te an o ff er to s ell, o r th e s o li c itation of an off e r t o buy, any sec u riti e s in t h e Un i te d S t at e s o r t o , or f o r t h e a c co u nt or be n ef i t o f , a n y p e r so n in th e Unit e d S ta t es . No a cti o n h a s b e en or wil l b e ta k e n to re g ist e r, q u ali f y o r oth e rwise pe r mi t a p u b lic off e ri n g o f t h e N e w Sha r es in a n y ju r isdicti o n o utsid e A us t ralia a nd N e w Ze a la n d. In parti c ular, t h e N e w S ha r es and N e w O p ti o ns ha v e n ot be e n, a n d w ill n ot be, regis t er e d u n d er the U n ite d S tat e s S e c uritie s A c t o f 1 9 3 3 ( US Securities Act ) or th e s e cu r iti e s l a w s o f any s t at e o r ot h er ju r isdicti o n o f t h e Un i te d S t at e s. Ac c or d in g ly , th e entitle m ents m a y n o t b e t a k e n u p a n d t he N e w S h a re s a n d N e w O pti o n s m a y n ot be is s ue d t o , p u rcha s ed or tra d e d b y , or t a ke n u p o r e x er c ised b y, a n y p e rs o n i n t h e U ni t ed St a te s o r a n y p er s on ac t in g for t h e a cc o u n t o r b e nefit o f a p e rs o n in t h e U nited St a te s e x c e pt p u r su a nt to a n e x e m p tio n f r om, o r in a t r ansa c tion not s ub j ec t to, the r e gi s tr a tio n r e quire m e n ts of t he U S S e curiti e s A ct an d applica b le U n ite d S t at e s s tate sec u riti e s la w s.